Efficacy and safety of oral upadacitinib-topical ruxolitinib combination therapy in the treatment of progressive nonsegmental vitiligo.

Li W, Gao J, Huang H, Zhu T, Tang X, Zhang R, Chen X, Wang Y, Zhang Y, Zhang X, Cui Y, Zhou Y, Zhang B

DOI: 10.1016/j.jdin.2025.04.014
Published: 2025 Oct
Container: JAAD international
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jdin.2025.04.014,
  title = {Efficacy and safety of oral upadacitinib-topical ruxolitinib combination therapy in the treatment of progressive nonsegmental vitiligo.},
  author = {Li W and Gao J and Huang H and Zhu T and Tang X and Zhang R and Chen X and Wang Y and Zhang Y and Zhang X and Cui Y and Zhou Y and Zhang B},
  year = {2025},
  journal = {JAAD international},
  doi = {10.1016/j.jdin.2025.04.014},
  url = {https://doi.org/10.1016/j.jdin.2025.04.014}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of oral upadacitinib-topical ruxolitinib combination therapy in the treatment of progressive nonsegmental vitiligo.
AU  - Li W
AU  - Gao J
AU  - Huang H
AU  - Zhu T
AU  - Tang X
AU  - Zhang R
AU  - Chen X
AU  - Wang Y
AU  - Zhang Y
AU  - Zhang X
AU  - Cui Y
AU  - Zhou Y
AU  - Zhang B
PY  - 2025
JO  - JAAD international
DO  - 10.1016/j.jdin.2025.04.014
UR  - https://doi.org/10.1016/j.jdin.2025.04.014
ER  -

APA

W, L., J, G., H, H., T, Z., X, T., R, Z., X, C., Y, W., Y, Z., X, Z., Y, C., Y, Z., & B, Z. (2025). Efficacy and safety of oral upadacitinib-topical ruxolitinib combination therapy in the treatment of progressive nonsegmental vitiligo.. JAAD international. https://doi.org/10.1016/j.jdin.2025.04.014

Source records

pubmed · retrieved 2026-09-25T05:48:27.862Z